Article

Italian campaign to abolish red tape, help patients with glaucoma

Rome-Tiziana Fattori, MD, of Per Vedere Fatti Vedere onlus in Italy explained the reasons behind the launch of a campaign to abolish bureaucratic procedures inhibiting patients from undertaking treatment for glaucoma.

Rome-Tiziana Fattori, MD, of Per Vedere Fatti Vedere Onlus in Italy, explained the reasons behind the launch of a campaign to abolish bureaucratic procedures inhibiting patients from undertaking treatment for glaucoma.

“Between 2004 and 2005 a specific procedure for patients to obtain a National Health Service (NHS) reimbursement for medicines used in glaucoma treatment was established in Italy. This procedure is called Nota 78 and is subject to the control of AIFA, the Italian agency for pharmaceutical products,” Dr. Fattori added.

“Under the current procedure once a year, but in some regions even twice or three times a year, every patient with glaucoma has to submit a therapeutic plan, drafted and signed by an ophthalmologist, that lists all the medicines used for treating glaucoma,” Dr. Fattori said. “This document must be drafted in three copies: one copy needs to be handed to his or her NHS physician, one copy sent to the NHS, and one copy kept in a file. Only if you undertake this cumbersome procedure can you obtain the NHS reimbursement for your glaucoma treatment. The therapeutic plan is always the same, given the chronic nature of the disease and therefore it does not make any sense to repeat the procedure on a regular basis, producing an enormous paperwork and waste of time for patients, physicians, and NHS.

“Alarmingly, recent research undertaken in Emilia Romagna has shown that, since this procedure [has been] in place, an increasing percentage of glaucoma patients are not taking any treatment for glaucoma, most likely due to having to cope with this bureaucratic and absurd procedure, typical of some ancient inheritance of our country,” he added.

“So, on World Glaucoma Day, Per Vedere Fatti Vedere Onlus is inviting Italian glaucoma patients, their families, NHS doctors, and ophthalmologists to send a message of protest-by fax or e-mail to AIFA and the Ministry of Health asking the abolition of this oppressive burden currently imposed on patients with glaucoma. Whoever wants to participate in the campaign can visit our Web site www.pervederefattivedere.it, download the message of protest, and fax or e-mail details and send their message.”

Media coverage also is planned to support this campaign.

Dr. Fattori may be contacted by phone at +39 06 44361575 or e-mail at fattori@pervederefattivedere.it.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.